Report overview
This report contains market size and forecasts of Approved COVID-19 Vaccines in global, including the following market information:
Global Approved COVID-19 Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Approved COVID-19 Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Approved COVID-19 Vaccines companies in 2021 (%)
The global Approved COVID-19 Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Component Viral Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Approved COVID-19 Vaccines include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson?Johnson, Heat Biologics and Sanofi. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Approved COVID-19 Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Approved COVID-19 Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Approved COVID-19 Vaccines Market Segment Percentages, by Type, 2021 (%)
Component Viral Vaccines
Whole Virus Vaccines
Global Approved COVID-19 Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Approved COVID-19 Vaccines Market Segment Percentages, by Application, 2021 (%)
Adults
Children
Elderly
Global Approved COVID-19 Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Approved COVID-19 Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Approved COVID-19 Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Approved COVID-19 Vaccines revenues share in global market, 2021 (%)
Key companies Approved COVID-19 Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Approved COVID-19 Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson?Johnson
Heat Biologics
Sanofi
